Clinical Trial Update: Cell Therapy for Coronary Heart Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a cell therapy for coronary artery disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Coronary Artery Disease | Phase 2 | Status: TERMINATED